Oncoscience

Volume 1: Issue 1

pp1-110

Issue 1

News

Introducing Oncoscience: from Oncotarget to the future

https://doi.org/10.18632/oncoscience.14

PDF

Editorials

Targeting glutamine uptake in AML

https://doi.org/10.18632/oncoscience.1

Nathalie  Jacque, Didier  Bouscary

p 1-2

PDF

MicroRNA in drug resistance

https://doi.org/10.18632/oncoscience.2

Haoran  Li, Burton B. Yang

p 3-4

PDF

Reviews

Cross talk between two antioxidant systems, Thioredoxin and DJ-1: consequences for cancer

https://doi.org/10.18632/oncoscience.12

Prahlad V. Raninga, Giovanna  Di Trapani, Kathryn F. Tonissen

p 95-110

Abstract |  PDF |  Full Text

Research Papers

MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitors

https://doi.org/10.18632/oncoscience.3

Chad  Tang, Denis L. Fontes Jardim, Gerald S. Falchook, Kenneth  Hess, Siqing  Fu, Jennifer J. Wheler, Ralph G. Zinner, Aung  Naing, Apostolia M. Tsimberidou, Debora  De Melo Galgiato, Shannon N. Westin, Funda  Meric-Bernstam, Razelle  Kurzrock, David S. Hong

p 5-13

Abstract |  PDF |  Full Text

Expression of Cancer/Testis genes in ductal carcinoma in situ and benign lesions of the breast

https://doi.org/10.18632/oncoscience.4

Otavia L. Caballero, Sami  Shousha, Qi  Zhao, Andrew J. G. Simpson, R. Charles  Coombes, A. Munro  Neville

p 14-20

Abstract |  PDF |  Full Text |  Supplementary Materials

Disulfiram/copper causes redox-related proteotoxicity and concomitant heat shock response in ovarian cancer cells that is augmented by auranofin-mediated thioredoxin inhibition

https://doi.org/10.18632/oncoscience.5

Margarita  Papaioannou, Ioannis  Mylonas, Richard E. Kast, Ansgar  Bruning

p 21-29

Abstract |  PDF |  Full Text

Interplay between HGF/SF‒Met-Ras signaling, tumor metabolism and blood flow as a potential target for breast cancer therapy

https://doi.org/10.18632/oncoscience.6

Sari  Natan, Galia  Tsarfaty, Judith  Horev, Roni  Haklai, Yoel  Kloog, Ilan  Tsarfaty

p 30-38

Abstract |  PDF |  Full Text

Novel LIMK2 inhibitor blocks Panc-1 tumor growth in a mouse xenograft model

https://doi.org/10.18632/oncoscience.7

Roni  Rak, Roni  Haklai, Galit  Elad-Tzfadia, Haim J. Wolfson, Shmuel  Carmeli, Yoel  Kloog

p 39-48

Abstract |  PDF |  Full Text

Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients

https://doi.org/10.18632/oncoscience.8

Elisabetta  Rossi, Massimo  Rugge, Antonella  Facchinetti, Marco  Pizzi, Giorgia  Nardo, Vito  Barbieri, Mariangela  Manicone, Stefania  De Faveri, Maria Chiara Scaini, Umberto  Basso, Alberto  Amadori, Rita  Zamarchi

p 49-56

Abstract |  PDF |  Full Text

Modeling the influence of stromal microenvironment in the selection of ENU-induced BCR-ABL1 mutants by tyrosine kinase inhibitors

https://doi.org/10.18632/oncoscience.9

Djamel  Aggoune, Lucie  Tosca, Nathalie  Sorel, Marie-Laure  Bonnet, Fatima  Dkhissi, Gerard  Tachdjian, Annelise  Bennaceur-Griscelli, Jean-Claude  Chomel, Ali G.  Turhan

p 57-68

Abstract |  PDF |  Full Text |  Supplementary Materials

Expression profiling of migrated and invaded breast cancer cells predicts early metastatic relapse and reveals Krüppel-like factor 9 as a potential suppressor of invasive growth in breast cancer

https://doi.org/10.18632/oncoscience.10

Ridha  Limame, Ken  Op de Beeck, Steven  Van Laere, Lieselot  Croes, Annemieke  De Wilde, Luc  Dirix, Guy  Van Camp, Marc  Peeters, Olivier  De Wever, Filip  Lardon, Patrick  Pauwels

p 69-81

Abstract |  PDF |  Full Text

Melanoma brain colonization involves the emergence of a brain-adaptive phenotype

https://doi.org/10.18632/oncoscience.11

Vigdis  Nygaard, Lina  Prasmickaite, Kotryna  Vasiliauskaite, Trevor  Clancy, Eivind  Hovig

p 82-94

Abstract |  PDF |  Full Text |  Supplementary Materials